DiagnOptics Technologies BV

Exhibiton
No items found.
No items found.

Diagnoptics develops and markets non-invasive diagnostic technologies to assess cardiovascular risk and the risk of diabetes. The extensively validated AGE Reader enables a doctor to non-invasively assess the cardiovascular risk of their patients within 12 seconds.<br /> The measurement result can be exported directly to a software application to generate cardiovascular risk reports that also include the classic risk factors.<br /> New validation studies also show great promise for diabetes screening.